IUB® SEAD®
Abnormal uterine bleeding / heavy menstrual bleeding
Phase 2Active
Key Facts
Indication
Abnormal uterine bleeding / heavy menstrual bleeding
Phase
Phase 2
Status
Active
Company
About OCON Therapeutics
Innovative Nitinol‑based intrauterine platform delivering hormone‑free contraception and targeted therapies for women’s health.
View full company profile